Full text is available at the source.
Abstract
A high proportion of patients with pheochromocytomas and paragangliomas show glycemic dysregulation.
- Pheochromocytomas and paragangliomas are associated with abnormal blood sugar levels.
- There is a lack of studies investigating the impact of anti-diabetic medications on tumor growth in these patients.
- Understanding the relationship between glycemic control and tumor behavior may be important for patient management.
Simplified